Finally CYTR arrived to broke $1, but we're very far from R/S price $2,4 or from expectations of Aldoxorubicin phase3 in Summer of 2017, when Soon-Shiong jumped in at $6.6! Maybe next year something bigger could happen with Aldox and Aromoclomol.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.